Clinical trial
Vinorelbine and/or Gemcitabine in Treating Older Patients With Stage IIIB or…
NCT00003447 · Istituto Nazionale per lo Studio e la Cura dei Tumori, Other · Unknown status
Key facts
| NCT number | NCT00003447 |
|---|---|
| Title | Vinorelbine and/or Gemcitabine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer |
| Official title | Vinorelbine Versus Gemcitabine Versus Gemcitabine and Vinorelbine in Elderly Patients With Stage IIIB-IV Non-Small Cell Lung Cancer |
| Lead sponsor | Istituto Nazionale per lo Studio e la Cura dei Tumori, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | gemcitabine hydrochloride, vinorelbine tartrate |
| Enrollment | 630 |
| Start date | Jul 1, 1998 |
| First posted | May 21, 2004 |
| Last update posted | Dec 19, 2013 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: